The Rise of GIP: From Biology to Medicine

Show notes

Delve into the evolving story of GIP-based therapies and their role in type 2 diabetes care. In this episode, our expert guests explore how dual and triple agonists like tirzepatide are reshaping obesity and metabolic control, and why GIP is gaining renewed attention in diabetes pharmacology.

You can also explore each speakers' profiles as well as watch each speaker’s Lecturesession from the EASD Annual Meeting 2024 for deeper insights into incretin science, clinical outcomes, and next-generation therapies:

New comment

Your name or nickname, will be shown publicly
At least 10 characters long
By submitting your comment you agree that the content of the field "Name or nickname" will be stored and shown publicly next to your comment. Using your real name is optional.